A case of simultaneously occurring lichen sclerosus and segmental vitiligo: Connecting the underlying autoimmune pathogenesis

International Journal of Dermatology

Volumn 47, Issue 10, 2008, Pages 1053-1055

  Weisberg, Eric L ^a   Le, Lu Q ^a   Cohen, Jack B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL;

ADULT; AFRICAN AMERICAN; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DEPIGMENTATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; LICHEN SCLEROSUS ET ATROPHICUS; PATHOGENESIS; PUNCH BIOPSY; SCLERODERMA; SKIN ATROPHY; SKIN BURNING SENSATION; VAGINAL PRURITUS; VITILIGO;

ADULT; CLOBETASOL; FEMALE; GLUCOCORTICOIDS; HUMANS; VITILIGO; VULVAR LICHEN SCLEROSUS;

EID: 54749118611     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03623.x     Document Type: Article

References (16)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
2. Lerner AB, Norland JJ. Vitiligo: The loss of pigment in skin, hair, and eyes. J Dermatol 1978; 5: 1.
3. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000; 13(Suppl. 8): 41-47.
4. Hann SK, Lee HJ. Segmental vitiligo: Clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-674.
5. Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 1986; 15: 978-998.
6. Tasker GL, Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol 2003; 28: 128-133.
7. Oyama N, Chan I, Niell S, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118-123.
8. Carlson JA, Grabowski R, Mu XC, et al. Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol 2002; 24: 97-107.
9. Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002; 138: 77-87.
10. Slominski A, Paus R. Hypothesis: A possible for the melatonin receptor in vitiligo. J R Soc Med 1989; 82: 539-541.
11. Egan CA, Bradley RR, Logston VK, et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133: 345-348.
12. Chan LS, Vanderglut CJ, Hashimoto T, et al. Epitope spreading: Lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110: 103.
13. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin Exp Dermatol 1998; 13: 36-37.
14. Levine EL, Ribeiro GG. Vitiligo and radiotherapy; the Koebner phenomenon demonstrated in patients with vitiligo undergoing radiotherapy for carcinoma of the breast. Clin Oncol 1994; 6: 133-134.
15. Riordan AT, Nahass GT. Occupational vitiligo following allergic contact dermatitis. Contact Dermatitis 1996; 34: 371.
16. Papadavid E, Yu RC, Munn S, et al. Strict anatomical coexistence of vitiligo and psoriasis vulgaris. Clin Exp Dermatol 1996; 21: 138-140.